Radiation Oncology Journal

REVIEW ARTICLE 2021 October 25 Abscopal effect in the radio and immunotherapy
This review is devoted to a rare in clinical practice, but promising phenomenon of regression distant non-irradiated metastases in combination therapy of cancer patients. R. H. Mole in 1953 suggested introducing the term “abscopal effect” to denote the effect of ionizing radi...

ORIGINAL ARTICLE 2021 October 26 Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases
Purpose: Radiomic models elaborate geometric and texture features of tumors extracted from imaging to develop predictors for clinical outcomes. Stereotactic body radiation therapy (SBRT) has been increasingly applied in the ablative treatment of thoracic tumors. This study aims ...

ORIGINAL ARTICLE 2021 September 3 Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer
Purpose: Re-irradiation is a treatment option for recurrent esophageal cancer patients with a history of radiotherapy, but there is a risk of severe late adverse effects. This study focused on the efficacy and safety of re-irradiation using hyperfractionated radiotherapy. Mate...

ORIGINAL ARTICLE 2021 October 26 Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients
Purpose: This study was performed to investigate the efficacy and safety of short-course radiation therapy (SCRT) and sequential chemotherapy followed by delayed surgery in locally advancer rectal cancer with subgroup analysis between the older and young patients. Materials and...

ORIGINAL ARTICLE 2021 December 7 Re-irradiation for recurrent or second primary head and neck cancer
Purpose: To investigate the efficacy and safety of intensity-modulated radiotherapy (IMRT)-based re-irradiation (reRT) for recurrent or second primary head and neck cancer (HNC). Materials and Methods: Patients who underwent IMRT-based reRT for recurrent or second primary HNC b...

ORIGINAL ARTICLE 2021 December 8 Clinical features and treatment outcomes of resected large cell neuroendocrine carcinoma of the lung
Purpose: Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a high-grade lung neuroendocrine tumor with a poor prognosis, similar to small cell lung cancer (SCLC). However, it remains unclear whether to treat LCNEC as non-small-cell lung cancer (NSCLC) or as SCLC. We revie...

ORIGINAL ARTICLE 2021 December 14 Prognostic value of the maximum standardized uptake value for the locoregional control in early glottic cancer
Purpose: To evaluate the prognostic value of the pretreatment maximum standardized uptake value (SUVmax) for locoregional control (LRC) of early glottic cancer treated with primary radiotherapy. Materials and Methods: We retrospectively reviewed the medical records of 101 patie...

ORIGINAL ARTICLE 2021 December 17 Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
Purpose: The purpose of this study was to determine if somatic mutations are associated with clinical and pathologic outcomes in patients with borderline resectable pancreatic cancer (BRPC) or locally advanced pancreatic cancer (LAPC) who were treated with neoadjuvant chemothera...

ORIGINAL ARTICLE 2021 December 24 Clinical factors affecting the determination of radiotherapy-induced skin toxicity in breast cancer
Purpose: Radiotherapy is essential for the treatment of breast cancer (BC). However, adverse effects may occur in healthy tissue, during treatment and even after several months. Although it is known that this clinical radiosensitivity is multifactorial, the factors involved are ...

ORIGINAL ARTICLE 2021 August 17 Gamma-ray irradiation modulates PGRMC1 expression and the number of CD56⁺ and FoxP3⁺ cells in the tumor microenvironment of endometrial endometrioid adenocarcinoma
Purpose: Although the conventional gamma ray brachytherapy has been successful in treating endometrioid endometrial adenocarcinoma (EC), the molecular and cellular mechanisms of this anti-tumorigenic response remain unclear. Therefore, we investigated whether gamma ray irradiati...

If anyone registers his/her email address, he or she will receive the email of notification when new paper is published in the web site of Radiation Oncology Journal. Since it is open access journal, the full text is freely available.
Please Sign up.

Current Issue

Volume 39(4); December 2021

This archive contains links to the full-text of all issues of Radiat Oncol J

Current Issue

Volume 39, No 4

All Issues

Vol. 39
2021

v.39(1)
Mar 2021

v.39(2)
Jun 2021

v.39(3)
Sep 2021

v.39(4)
Dec 2021

Vol. 38
2020

v.38(1)
Mar 2020

v.38(2)
Jun 2020

v.38(3)
Sep 2020

v.38(4)
Dec 2020

Vol. 37
2019

v.37(1)
Mar 2019

v.37(2)
Jun 2019

v.37(3)
Sep 2019

v.37(4)
Dec 2019

Vol. 36
2018

v.36(1)
Mar 2018

v.36(2)
Jun 2018

v.36(3)
Sep 2018

v.36(4)
Dec 2018

Vol. 35
2017

v.35(1)
Mar 2017

v.35(2)
Jun 2017

v.35(3)
Sep 2017

v.35(4)
Dec 2017

Vol. 34
2016

v.34(1)
Mar 2016

v.34(2)
Jun 2016

v.34(3)
Sep 2016

v.34(4)
Dec 2016

Vol. 33
2015

v.33(1)
Mar 2015

v.33(2)
Jun 2015

v.33(3)
Sep 2015

v.33(4)
Dec 2015

Vol. 32
2014

v.32(1)
Mar 2014

v.32(2)
Jun 2014

v.32(3)
Sep 2014

v.32(4)
Dec 2014

Vol. 31
2013

v.31(1)
Mar 2013

v.31(2)
Jun 2013

v.31(3)
Sep 2013

v.31(4)
Dec 2013

Vol. 30
2012

v.30(1)
Mar 2012

v.30(2)
Jun 2012

v.30(3)
Sep 2012

v.30(4)
Dec 2012

Vol. 29
2011

v.29(3)
Sep 2011

v.29(4)
Dec 2011

The Journal of the Korean Society for Therapeutic Radiology and Oncology
1998 (v16 n1) to 2011 (v29 n2)

Vol. 29
2011

v.29(1)
2011

v.29(2)
2011

Vol. 28
2010

v.28(1)
2010

v.28(2)
2010

v.28(3)
2010

v.28(4)
2010

Vol. 27
2009

v.27(1)
2009

v.27(2)
2009

v.27(3)
2009

v.27(4)
2009

Vol. 26
2008

v.26(1)
2008

v.26(2)
2008

v.26(3)
2008

v.26(4)
2008

Vol. 25
2007

v.25(1)
2007

v.25(2)
2007

v.25(3)
2007

v.25(4)
2007

Vol. 24
2006

v.24(1)
2006

v.24(2)
2006

v.24(3)
2006

v.24(4)
2006

Vol. 23
2005

v.23(1)
2005

v.23(2)
2005

v.23(3)
2005

v.23(4)
2005

Vol. 22
2004

v.22(1)
2004

v.22(2)
2004

v.22(3)
2004

v.22(4)
2004

Vol. 21
2003

v.21(1)
2003

v.21(2)
2003

v.21(3)
2003

v.21(4)
2003

Vol. 20
2002

v.20(1)
2002

v.20(2)
2002

v.20(3)
2002

v.20(4)
2002

Vol. 19
2001

v.19(1)
2001

v.19(2)
2001

v.19(3)
2001

v.19(4)
2001

Vol. 18
2000

v.18(1)
2000

v.18(2)
2000

v.18(3)
2000

v.18(4)
2000

Vol. 17
1999

v.17(1)
1999

v.17(2)
1999

v.17(3)
1999

v.17(4)
1999

Vol. 16
1998

v.16(1)
1998

v.16(2)
1998

v.16(3)
1998

v.16(4)
1998

Journal of the Korean Society for Therapeutic Radiology1983 (v1 n1) to 1997 (v15 n4)

Vol. 15
1997

v.15(1)
1997

v.15(2)
1997

v.15(3)
1997

v.15(4)
1997

Vol. 14
1996

v.14(1)
1996

v.14(2)
1996

v.14(3)
1996

v.14(4)
1996

Vol. 13
1995

v.13(1)
1995

v.13(2)
1995

v.13(3)
1995

v.13(4)
1995

Vol. 12
1994

v.12(1)
1994

v.12(2)
1994

v.12(3)
1994

Vol. 11
1993

v.11(1)
1993

v.11(2)
1993

Vol. 10
1992

v.10(1)
1992

v.10(2)
1992

Vol. 9
1991

v.9(1)
1991

v.9(2)
1991

Vol. 8
1990

v.8(1)
1990

v.8(2)
1990

Vol. 7
1989

v.7(1)
1989

v.7(2)
1989

Vol. 6
1988

v.6(1)
1988

v.6(2)
1988

Vol. 5
1987

v.5(1)
1987

v.5(2)
1987

Vol. 4
1986

v.4(1)
1986

v.4(2)
1986

Vol. 3
1985

v.3(1)
1985

v.3(2)
1985

Vol. 2
1984

v.2(1)
1984

v.2(2)
1984

Vol. 1
1983

v.1(1)
1983

Principles of Transparency and Best Practice

Editorial Office Department of Radiation Oncology, Seoul National University Hospital, Hamchun Hall, 6F, 95 Daehak-ro, Jongno-gu, Seoul 03082, Republic of Korea Tel : +82-2-743-6574 E-mail: roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.